Condition
Poliomyelitis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Poliomyelitis clinical trials that are recruiting, at sites in 4 countries (most in China (2), Bangladesh (2), Panama (2)). 1 was first registered in the last 30 days. By phase: Phase 4 (2), Phase 1/2 (2), Phase 2 (2), Phase 3 (1). The most active sponsors are Path (3), Sinovac Biotech Co., Ltd (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 4Countries
Newest Poliomyelitis clinical trials
All recruiting trials (7)
-
Diphtheria, Tetanus, Pertussis, and Poliovirus Vaccine Trial in Young Children
This is a small early-phase study testing a diphtheria, tetanus, pertussis and polio vaccine formulation in children from 2 months to 6 years to see if it is safe and can provoke an immune response.
-
Sequential vaccination with Sabin-strain and wild-strain inactivated polio vaccines
It will test different combinations and injection routes of inactivated polio vaccines in healthy 2-month-old infants to see if they produce strong antibody protection with good safety.
-
One-dose Sabin inactivated polio vaccine (sIPV) in adolescents and adults versus three-dose DTaP‑IPV‑Hib in infants
This will try one dose of Sabin inactivated poliovirus vaccine (sIPV) in people aged 7–50 to see if it gives similar antibody protection and safety as three doses of DTaP‑IPV‑Hib given to infants.
-
Birth-dose nOPV2 in IPV-primed newborns for poliovirus type 2 transmission
This study tests whether newborns who receive a birth-dose nOPV2, after initial IPV priming, show limited transmission of poliovirus type-2 in their stool.
-
Co-administration of novel oral polio vaccines types 1 and 2 in infants
This study will test whether giving infants both new oral type 1 and type 2 polio vaccines together is safe and produces immune responses similar to giving each vaccine alone.
-
New trivalent and combined type 1 & 2 oral polio vaccines
This tests whether new trivalent and combined type 1+2 oral polio vaccines are safe and produce protective antibody responses in healthy adults, young children, and newborns.
-
Evaluation of a new oral polio vaccine in children
This study is testing a new oral polio vaccine in healthy young children to see if it is safe and works better than the current vaccine.
Related topics
Quick answers
How many Poliomyelitis clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), Bangladesh (2 trials), Panama (2 trials), Philippines (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 1/2: 2, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.